Oral Abstract Schedule

Friday Resident Oral Abstract Schedule

Eastern TimePRESENTERABSTRACT TITLE
RESIDENT ABSTRACTS
11:00 am - 11:15 amSamuel KeepmanSAFETY EVALUATION OF LOW DOSE MELOXICAM WITH TOCERANIB PHOSPHATE
(PALLADIA) IN CANCER BEARING CATS: A PHASE I DOSE-FINDING STUDY
11:15 am - 11:30 amGabrielle CarterLOMUSTINE BASED CHEMOTHERAPY PROTOCOLS FOR THE TREATMENT
OF CANINE T-CELL LYMPHOMA
11:30 am - 11:45 amCaroline MurrayOUTCOME IN 27 DOGS WITH CURATIVE-INTENT TREATMENT OF LOCALIZED
PRIMARY PULMONARY HISTIOCYTIC SARCOMA
11:45 am - 12:00 pmJennifer CarrollFIRST IN PATIENT TRIAL OF HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)
FOR TREATMENT OF CANINE SOLID TUMORS
12:45 pm - 1:00 pmKara MageeA MULTIMODALITY RADIOIMMUNOTHERAPY APPROACH TO TREATING
ADVANCED STAGE CANCER IN COMPANION DOGS
1:00 pm - 1:15 pmAmanda BrehmSAFETY AND FEASIBILITY OF WHOLE LUNG IRRADIATION IN THE TREATMENT
OF CANINE APPENDICULAR OSTEOSARCOMA
1:15 pm - 1:30 pmBrittany FeldhaeusserPROTEASOME INHIBITION VIA BORTEZOMIB INDUCES APOPTOSIS IN
CANINE GLIOMA CELLS
1:30 pm - 1:45 pmChristopher DolanCHARACTERIZING CIRCULATING NUCLEOSOMES IN THE PLASMA OF
DOGS WITH LYMPHOMA
1:45 pm - 2:00 pmChristopher PinardPD-1 AND PD-L1 EXPRESSION ON CANINE UROTHELIAL CARCINOMA
CELL LINES AND THE RELATIVE EXPRESSION OF LYMPHOCYTE PD-1 IN
CANINE UROTHELIAL CARCINOMA PATIENTS

 

Friday International Oral Abstract Track One

Eastern TimePRESENTERABSTRACT TITLE
RESIDENT ABSTRACTS
11:00 am - 11:15 amLaurien FeenstraMINIMAL DOSE EFFICACY OF PEG-L-ASPARAGINASE IN HEALTHY BEAGLE DOGS
11:15 am - 11:30 amPierre BoyePHASE I DOSE ESCALATION STUDY OF 12B80 – HYDROXYBISPHOSPHONATE
LINKED DOXORUBICIN – IN DOGS WITH NATURALLY OCCURRING OSTEOSARCOMA
11:30 am - 11:45 amTaylor DePauwMACHINE LEARNING FOR EARLY DETECTION OF HEMANGIOSARCOMA
11:45 am - 12:00 pmSungwon LimPREDICTING LIKELIHOOD OF IN VIVO CHEMOTHERAPY RESPONSE IN CANINE
LYMPHOMA USING EX VIVO DRUG SENSITIVITY AND IMMUNOPHENOTYPING DATA
IN A MACHINE LEARNING MODEL
12:45 pm - 1:00 pmTomiyasu HiratakaAN EXPLORATORY INVESTIGATION OF NOVEL MOLECULAR TARGETS
FOR CHEMOTHERAPY IN CANINE HISTIOCYTIC SARCOMA
1:00 pm - 1:15 pmBenoit HédanCANINE HISTIOCYTIC SARCOMA: FROM THE GENETIC PREDISPOSITIONS
AND SOMATIC ALTERATIONS TO THE DEVELOPMENT OF A GENETIC
RISK TEST AND THERAPEUTIC OPTIONS
1:15 pm - 1:30 pmAnais ProuteauCIRCULATING TUMOR DNA AS A NOVEL BIOMARKER FOR CANINE CANCERS:
HISTIOCYTIC SARCOMA, ORAL MELANOMA AND LYMPHOMA
1:30 pm - 1:45 pmSabine BrandtRECOMBINANT LIVE-ATTENUATED INFLUENZA VIRUSES CO-EXPRESSING
BOVINE PAPILLOMAVIRUS 1 (BPV1) E6 AND E7 INDUCE TUMOUR
REGRESSION IN EQUINE SARCOID PATIENTS

 

Friday International Oral Abstract Track Two

Eastern TimePRESENTERABSTRACT TITLE
RESIDENT ABSTRACTS
11:00 am - 11:15 amEliza Vazquez-SanchezCANINE TRANSMISSIBLE VENEREAL TUMOR: RETROSPECTIVE STUDY OF
50 CASES DIAGNOSED DURING THE PERIOD OF 2016- 2019 IN MEXICO
11:15 am - 11:30 amKazushi AsanoEN BLOC RESECTION OF EXTENSIVE ADRENAL PHEOCHROMOCYTOMA INCLUDING
THE CAUDAL VENA CAVA IN DOGS
12:45 pm - 1:00 pmLuigi AurisschioELECTRO-IMMUNO-THERAPY IN VETERINARY MEDICINE: ACTIVATING
LOCAL AND SYSTEMIC IMMUNITY

 

Saturday Oral Abstract Schedule Track One

Eastern TimePRESENTERABSTRACT TITLE
SATURDAY ORAL ABSTRACTS TRACK ONE
11:00 am - 11:15 amShunsuke NoguchiMIR-190A/NRG3/ERBB4 CASCADE AS A POTENTIAL THERAPEUTIC
TARGET OF CANINE GLIOMA
11:15 am - 11:30 amAnna Luiza
Facchetti
Vinhaes Assumpcao
STAT3 PATHWAY IS UPREGULATED IN CANINE T-CELL LYMPHOMA
11:30 am - 11:45 amMargaret Musser ADVERSE EVENT PROFILE OF THE THERAPEUTIC CANINE OSTEOSARCOMA
VACCINE, LIVE LISTERIA VECTOR
11:45 am - 12:00 pmLisa ParshleyNANOPARTICLE AND LASER ABLATION OF SOLID TUMORS IN DOGS AND CATS
2:00 pm - 2:15 pmAbby ReisingSOLITARY OSSEOUS PLASMACYTOMAS IN DOGS: A RETROSPECTIVE
REVIEW OF 13 CASES
2:15 pm - 2:30 pmConstanza Pereira RiveraRETROSPECTIVE STUDY OF FELINE MEDIASTINAL LYMPHOMA:
PRESENTATION AND RESPONSE TO CHEMOTHERAPY TREATMENT
2:30 pm - 2:45 pmHiroki YamazakiRADIOTHERAPY ALONE VERSUS CHEMOTHERAPY FOLLOWED BY
RADIOTHERAPY FOR CATS WITH NASAL LYMPHOMA
2:45 pm - 3:00 pmAlycen LundbergCOMBINING ZOLEDRONATE WITH RADIATION THERAPY TO ENHANCE THE
TREATMENT OF OSTEOINVASIVE FELINE ORAL SQUAMOUS CELL CARCINOMA
3:00 pm - 3:15 pmHiroto YoshikawaRETROSPECTIVE EVALUATION OF FELINE INTRANASAL CARCINOMAS
TREATED WITH EXTERNAL-BEAM RADIOTHERAPY: 43 CASES
3:15 pm - 3:30 pmKim SeltingKINETICS OF CARDIAC TROPONIN I RELEASE AND CORRELATION WITH
ECHOCARDIOGRAPHIC AND ELECTROCARDIOGRAPHIC PARAMETERS IN
DOGS TREATED WITH SINGLE AGENT DOXORUBICIN

 

Saturday Oral Abstract Schedule Track Two

Eastern TimePRESENTERABSTRACT TITLE
SATURDAY ORAL ABSTRACTS TRACK ONE
11:00 am - 11:15 amGillian DankNON-INVASIVE DETECTION OF SPONTANEOUS TUMORS IN DOGS
11:15 am - 11:30 amHeather
Wilson-Robles
CHARACTERIZING CIRCULATING NUCLEOSOMES IN THE PLASMA OF DOGS
WITH HEMANGIOSARCOMA
11:30 am - 11:45 amJordan AyersNOVEL APPLICATION OF SINGLE CELL NEXT-GENERATION SEQUENCING FOR
DETERMINATION OF INTRATUMORAL HETEROZYGOSITY OF CANINE OSTEOSARCOMA
11:45 am - 12:00 pmKoangyong SungVISUALIZATION AND CHARACTERIZATION OF CANCER STEM CELLS WITH LOW
PROTEASOME ACTIVITY IN A CANINE OSTEOSARCOMA CELL LINE
2:00 pm - 2:15 pmAmandine LejeuneRNA IN-SITU HYBRIDIZATION AS A MOLECULAR DIAGNOSTIC TECHNIQUE TARGETING
IBA-1 AND CD204 IN CANINE HISTIOCYTIC SARCOMA
2:15 pm - 2:30 pmJordon InkolIN VITRO EFFECTS OF MONOACYLGLYCEROL LIPASE INHIBITION ON PHENOTYPE IN
CANINE UROTHELIAL CARCINOMA CELL LINES
2:30 pm - 2:45 pmGabriela ToledoREPURPOSING DRUGS IN VETERINARY CANCER TREATMENT: SODIUM DICHLOROACETATE
AND OMEPRAZOLE EXHIBIT SYNERGISTIC CYTOTOXIC EFFECTS ON CANINE
ORAL MELANOMA CELL LINE